company background image
EMBLA logo

Embla Medical hf CPSE:EMBLA Voorraadrapport

Laatste prijs

DKK 33.80

Marktkapitalisatie

DKK 14.4b

7D

1.5%

1Y

20.1%

Bijgewerkt

18 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Embla Medical hf.

CPSE:EMBLA Voorraadrapport

Marktkapitalisatie: DKK 14.4b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

EMBLA Overzicht aandelen

Embla Medical hf. levert samen met haar dochterondernemingen niet-invasieve orthopedische producten in Europa, het Midden-Oosten, Afrika, Noord- en Zuid-Amerika en Azië-Pacific.

Over het bedrijf

EMBLA fundamentele analyse
Sneeuwvlok Score
Waardering2/6
Toekomstige groei2/6
Prestaties in het verleden4/6
Financiële gezondheid3/6
Dividenden0/6

Beloningen

Verhandeld tegen 20.6% onder onze schatting van de reële waarde
De winst zal naar verwachting met 17.83% per jaar groeien
De winst groeide het afgelopen jaar met 35.3%

Risicoanalyse

Heeft een hoog schuldenniveau

Embla Medical hf. Concurrenten

Ambu

CPSE:AMBU B

DKK 34.5b

Demant

CPSE:DEMANT

DKK 58.6b

NuVasive

NasdaqGS:NUVA

US$2.1b

CONMED

NYSE:CNMD

US$2.0b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Embla Medical hf
Historische aandelenkoersen
Huidige aandelenkoersDKK 33.80
52 Week HoogtepuntDKK 35.70
52 Week LaagDKK 25.25
Bèta0.67
11 maand verandering9.74%
3 maanden verandering14.19%
1 Jaar Verandering20.07%
33 jaar verandering-25.71%
5 jaar verandering-28.69%
Verandering sinds IPO514.55%

Recent nieuws en updates

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Oct 17
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Oct 02
Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Recent updates

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Oct 17
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Oct 02
Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Apr 10
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Mar 23
Is Össur hf (CPH:OSSR) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Jan 21
Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 03
Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Nov 28
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

Sep 23
A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Aug 21
We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Jul 18
Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Jun 14
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

May 19
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 21
A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22
These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21
Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Aug 16
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Jun 16
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Jun 01
Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

May 08
Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Feb 22
Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Feb 03
Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Nov 25
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Oct 17
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Is Össur hf (CPH:OSSR) A Risky Investment?

Sep 28
Is Össur hf (CPH:OSSR) A Risky Investment?

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Aug 21
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Jul 11
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

May 28
Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

May 07
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Mar 25
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

Mar 02
We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Feb 22
We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

Feb 09
Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Jan 26
What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Jan 08
Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Rendement voor aandeelhouders

EMBLADK Medical EquipmentDK Markt
7D1.5%1.9%-0.9%
1Y20.1%22.8%19.7%

Rendement versus industrie: EMBLA presteerde slechter dan de Danish Medical Equipment -sector, die het afgelopen jaar een rendement van 23.8 % opleverde.

Rendement versus markt: EMBLA kwam overeen met de Danish markt, die het afgelopen jaar een rendement opleverde van 19.8 %.

Prijsvolatiliteit

Is EMBLA's price volatile compared to industry and market?
EMBLA volatility
EMBLA Average Weekly Movement3.4%
Medical Equipment Industry Average Movement5.6%
Market Average Movement4.2%
10% most volatile stocks in DK Market8.9%
10% least volatile stocks in DK Market2.4%

Stabiele aandelenkoers: EMBLA heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van EMBLA is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf. levert, samen met haar dochterondernemingen, niet-invasieve orthopedische producten in Europa, het Midden-Oosten, Afrika, Noord- en Zuid-Amerika en Azië-Pacific. Het bedrijf is actief in drie segmenten: Prothesiologie, Bracing & Supports en Patiëntenzorg.

Embla Medical hf. Samenvatting

Hoe verhouden de winst en inkomsten van Embla Medical hf zich tot de beurswaarde?
EMBLA fundamentele statistieken
MarktkapitalisatieDKK 14.43b
Inkomsten(TTM)DKK 419.45m
Inkomsten(TTM)DKK 5.63b

34.4x

Koers/Winstverhouding

2.6x

P/S-verhouding

Is EMBLA overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EMBLA resultatenrekening (TTM)
InkomstenUS$819.70m
Kosten van inkomstenUS$313.15m
BrutowinstUS$506.55m
Overige uitgavenUS$445.45m
InkomstenUS$61.10m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Oct 22, 2024

Winst per aandeel (EPS)0.14
Brutomarge61.80%
Nettowinstmarge7.45%
Schuld/Eigen Vermogen Verhouding54.3%

Hoe presteerde EMBLA op de lange termijn?

Bekijk historische prestaties en vergelijking